EUVIMEDEUVIMED entdecken
Open Access

Insertion of IS Pa1635 in IS CR1 Creates a Hybrid Promoter for bla PER-1 Resulting in Resistance to Novel β-lactam/β-lactamase Inhibitor Combinations and Cefiderocol

Leilei Wang, Xuefei Zhang, Xun Zhou, Yingmin Bi, Minggui Wang iD, Qinglan Guo iD, Fan Yang iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.00135-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Leilei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Pseudomonas Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eleven bla PER-1 -positive Pseudomonas aeruginosa clinical isolates showed variable susceptibility to ceftazidime-avibactam (CZA). The genetic contexts of bla PER-1 were identical (IS CR1 - bla PER-1 - gst ) except for the ST697 isolate HS204 (IS CR1 -IS Pa1635 - bla PER-1 - gst ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamase InhibitorsPseudomonas InfectionsHumansAnti-Bacterial AgentsLactamsPseudomonas aeruginosaCefiderocol

Stichwörter der Autor:innen

ISPa1635PER-1Pseudomonas aeruginosaTn6485gceftazidime-avibactampromoterresistance

Substanzen

beta-Lactamase InhibitorsAnti-Bacterial AgentsLactamsCefiderocol

Autor:innen und Institutionen

  • Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China.
  • Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.

ORCID-Profile: Minggui Wang, Qinglan Guo, Fan Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., Zhang, X., Zhou, X., Bi, Y., Wang, M., Guo, Q., & Yang, F. (2023). Insertion of IS Pa1635 in IS CR1 Creates a Hybrid Promoter for bla PER-1 Resulting in Resistance to Novel β-lactam/β-lactamase Inhibitor Combinations and Cefiderocol. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00135-23

Vancouver

Wang L, Zhang X, Zhou X, Bi Y, Wang M, Guo Q, et al. Insertion of IS Pa1635 in IS CR1 Creates a Hybrid Promoter for bla PER-1 Resulting in Resistance to Novel β-lactam/β-lactamase Inhibitor Combinations and Cefiderocol. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00135-23

BibTeX
@article{Wang2023,
  author = {Wang, Leilei and Zhang, Xuefei and Zhou, Xun and Bi, Yingmin and Wang, Minggui and Guo, Qinglan and Yang, Fan},
  title = {Insertion of IS Pa1635 in IS CR1 Creates a Hybrid Promoter for bla PER-1 Resulting in Resistance to Novel β-lactam/β-lactamase Inhibitor Combinations and Cefiderocol},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.00135-23}
}
Kostenlos starten →